Danhong injection reduces vascular remodeling and up-regulates the Kallikrein-kinin system in spontaneously hypertensive rats
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-04661-1.pdf
Reference64 articles.
1. He, J. et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet 374, 1765–1772 (2009).
2. Lewington, S. et al. The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA internal medicine 176, 524–532 (2016).
3. Oladapo, O. O. et al. Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study. Cardiovascular journal of Africa 23, 379–384 (2012).
4. Nadar, S. K., Tayebjee, M. H., Messerli, F. & Lip, G. Y. Target organ damage in hypertension: pathophysiology and implications for drug therapy. Current pharmaceutical design 12, 1581–1592 (2006).
5. Battegay, E. J., de Miguel, L. S., Petrimpol, M. & Humar, R. Effects of anti-hypertensive drugs on vessel rarefaction. Current opinion in pharmacology 7, 151–157 (2007).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Danhong formula alleviates endothelial dysfunction and reduces blood pressure in hypertension by regulating MicroRNA 24 - Phosphatidylinositol 3-Kinase-Serine/Threonine Kinase- Endothelial Nitric Oxide Synthase axis;Journal of Ethnopharmacology;2024-04
2. Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges;Frontiers in Pharmacology;2023-02-24
3. Differential action of pro-angiogenic and anti-angiogenic components of Danhong injection in ischemic vascular disease or tumor models;Chinese Medicine;2022-01-04
4. Maslinic acid in the treatment of heart damage in obesity hypertension through activating Nrf2 pathway;Food Science and Technology;2021-12-08
5. QiShenYiQi ameliorates salt-induced hypertensive nephropathy by balancing ADRA1D and SIK1 expression in Dahl salt-sensitive rats;Biomedicine & Pharmacotherapy;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3